MKI67 and breast carcinoma: For instance, in oestrogen receptor‐positive breast cancer patients who did not receive chemotherapy, CENPA could serve as an independent prognostic marker, and it was positively correlated with the Ki‐67 proliferation marker, which was also verified in the study of luminal A‐type breast cancer.26